Literature DB >> 6163957

The control of growth of mouse mastocytoma cells by N6,O2'-dibutyryladenosine cyclic 3',5'-monophosphate.

A Knightbridge, R K Ralph.   

Abstract

Addition of N6,O2'-Dibutyryladenosine cyclic 3',5'-monophosphate (DB cyclic AMP) plus theophylline or transfer to medium containing 0.2% serum slowed the growth of cultured mouse mastocytoma cells and eventually arrested their growth in G1 phase. Examination of the properties of cells arrested by either procedure suggested that the drugs arrested cells in G1 phase 1.5-2 h after the point of low serum arrest. Cycloheximide prevented the recovery of cell growth after low serum or drug-induced arrest demonstrating that protein synthesis was necessary to pass either growth restriction point. Cordycepin also prevented drug-arrested cells from progressing into cycle indicating a requirement for RNA synthesis to overcome the drug-induced growth arrest. Evidence is also presented that DB cyclic AMP prevented the cells receiving a pulse of calcium necessary to proceed past the DB cyclic AMP-sensitive growth restriction point. It is suggested that high cyclic AMP levels prevent mastocytoma cells from receiving a surge of calcium in G1 phase that is necessary if the cells are to proceed to S phase and eventually divide.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6163957     DOI: 10.1007/BF02359620

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  48 in total

1.  SYNTHESIS OF RNA AND PROTEIN REQUIRED FOR THE MITOSIS OF MAMMALIAN CELLS.

Authors:  S KISHIMOTO; I LIEBERMAN
Journal:  Exp Cell Res       Date:  1964-10       Impact factor: 3.905

2.  Ca2+ regulation of sarcoplasmic reticular protein phosphatase activity.

Authors:  M Varsányi; L M Heilmeyer
Journal:  Biochemistry       Date:  1979-10-30       Impact factor: 3.162

3.  Cyclic AMP and cyclic GMP content and binding in malignancy.

Authors:  M L Goldberg; G C Burke; H P Morris
Journal:  Biochem Biophys Res Commun       Date:  1975-01-20       Impact factor: 3.575

Review 4.  Role of cyclic nucleotides in growth control.

Authors:  I H Pastan; G S Johnson; W B Anderson
Journal:  Annu Rev Biochem       Date:  1975       Impact factor: 23.643

Review 5.  Relationships between calcium and cyclic nucleotides in cell activation.

Authors:  H Rasmussen; D B Goodman
Journal:  Physiol Rev       Date:  1977-07       Impact factor: 37.312

6.  Altered cyclic AMP-binding and db cyclic AMP-unresponsiveness in vivo.

Authors:  Y S Cho-Chung; T Clair
Journal:  Nature       Date:  1977-02-03       Impact factor: 49.962

7.  Regulation of cell growth by cyclic adenosine 3',5'-monophosphate. Effect of cell density and agents which alter cell growth on cyclic adenosine 3',5'-monophosphate levels in fibroblasts.

Authors:  J Otten; G S Johnson; I Pastan
Journal:  J Biol Chem       Date:  1972-11-10       Impact factor: 5.157

8.  Effects of isoleucine deficiency on nucleic acid and protein metabolism in cultured Chinese hamster cells. Continued ribonucleic acid and protein synthesis in the absence of deoxyribonucleic acid synthesis.

Authors:  M D Enger; R A Tobey
Journal:  Biochemistry       Date:  1972-01-18       Impact factor: 3.162

9.  Loss of proliferative calcium dependence: simple in vitro indicator of tumorigenicity.

Authors:  S H Swierenga; J F Whitfield; S Karasaki
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

10.  Correlation between cyclic AMP levels and calcium efflux in isolated renal cortical tubules.

Authors:  R W Wrenn; D M Biddulph
Journal:  J Cyclic Nucleotide Res       Date:  1979
View more
  2 in total

1.  Simian virus 40 small-t antigen-induced theophylline resistance is not mediated by cyclic AMP.

Authors:  C Renz; K Rundell
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

2.  Cyclic AMP, nuclear protein kinase and the PY815 cell cycle.

Authors:  M Goulding; R K Ralph
Journal:  Mol Cell Biochem       Date:  1985-05       Impact factor: 3.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.